Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dib

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|December 15, 2019
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusionsLindsay E Stoyka, Andrew E Arrant, Drake R Thrasher, et al.
Journal of Surgical Orthopaedic Advances|June 27, 2025
Shedding Sunshine on Gender Inequities in Industry Compensation to Physicians: a Centers for Medicare and Medicaid Services Open Payment AnalysisAdam M Almaguer, Kyle D Paul, Alexandra M Arguello, et al.
Shoulder & Elbow|March 4, 2024
Outcomes of the Latarjet procedure in female patients: A case series and matched-pair analysisAlexander N Berk, Anna M Ifarraguerri, Allison J Rao, et al.
JCO Oncology Practice|July 6, 2021
Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced CancerAmber S Kleckner, Megan Wells, Lee A Kehoe, et al.
The Oncologist|September 12, 2021
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced CancerNikesha Gilmore, Lee Kehoe, Jessica Bauer, et al.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
JCO Precision Oncology|June 14, 2023
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With <i>ERBB2</i> Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry StudyApar K Ganti, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With <i>BRAF</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|April 30, 2026
Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry StudyJohn K Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|January 20, 2022
Palbociclib in Patients With Non-Small-Cell Lung Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|December 15, 2019
Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusionsLindsay E Stoyka, Andrew E Arrant, Drake R Thrasher, et al.
Journal of Surgical Orthopaedic Advances|June 27, 2025
Shedding Sunshine on Gender Inequities in Industry Compensation to Physicians: a Centers for Medicare and Medicaid Services Open Payment AnalysisAdam M Almaguer, Kyle D Paul, Alexandra M Arguello, et al.
Shoulder & Elbow|March 4, 2024
Outcomes of the Latarjet procedure in female patients: A case series and matched-pair analysisAlexander N Berk, Anna M Ifarraguerri, Allison J Rao, et al.
JCO Oncology Practice|July 6, 2021
Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced CancerAmber S Kleckner, Megan Wells, Lee A Kehoe, et al.
The Oncologist|September 12, 2021
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced CancerNikesha Gilmore, Lee Kehoe, Jessica Bauer, et al.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
JCO Precision Oncology|June 14, 2023
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With <i>ERBB2</i> Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry StudyApar K Ganti, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With <i>BRAF</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|April 30, 2026
Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry StudyJohn K Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|January 20, 2022
Palbociclib in Patients With Non-Small-Cell Lung Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Pageof 6